Susan M. Chang

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical Applications

  American Journal of Neuroradiology · 2025-12-05 · 3 citations

• Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient community

  Neuro-Oncology Practice · 2025-11-14

• SURG-79. A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicenter, retrospective study with external validation by the RANO resect group

  Neuro-Oncology · 2025-11-01

• IMG-117. Characterization of recurrent IDH-mutant glioma using multiparametric1H/Hyperpolarized-13C MRI and histopathological analysis

  Neuro-Oncology · 2025-11-01 · 1 citations

• INNV-31. Development and durability of a peer-led adolescent and young adult (AYA) support group

  Neuro-Oncology · 2025-11-01

• IMG-97. Advancing hyperpolarized13C MRI for non-invasive assessment of blood-brain barrier integrity and IDH mutation status in glioma

  Neuro-Oncology · 2025-11-01

• QOL-16. ‘Living with Meningioma’: a longitudinal survey on patient-reported quality-of-life outcomes

  Neuro-Oncology · 2025-11-01

• TIP-08. Trial in progress update: A phase 1/2 study of intracranial and intravenous multi-dosing of DB107-RRV (formerly Toca 511) and DB107-FC (5-fluorocytosine) in combination with radiation ± temozolomide (TMZ) in patients with newly diagnosed high-grade gliomas (HGGs)

  Neuro-Oncology · 2025-11-01

• INNV-27. A coordinated care model for multidisciplinary meningioma treatment and research

  Neuro-Oncology · 2025-11-01

• Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation

  The Lancet Oncology · 2025-10-28 · 8 citations

• JS09.5.A SPATIAL TRANSCRIPTOMIC AND ELECTRODIAGNOSTIC PROFILING REVEALS SYNAPTIC CONNECTIVITY IS A HALLMARK OF OLIGODENDROGLIOMA RECURRENCE AND MALIGNANT TRANSFORMATION

  Neuro-Oncology · 2025-10-01

• Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma

  JCI Insight · 2025-09-22 · 3 citations

• Initial experience of characterizing recurrent IDH-mutant astrocytoma using multi-parametric 1H/HP-13C MRI and histopathological analysis

  Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2025-09-16

• Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI

  npj Digital Medicine · 2025-08-07 · 2 citations

• Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

  Neuro-Oncology · 2025-07-22 · 39 citations

• Point/counterpoint: The role of re-resection in recurrent glioblastoma

  Neuro-Oncology · 2025-07-21 · 3 citations

• The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective

  Neuro-Oncology · 2025-07-19 · 6 citations

• Web-based Dashboard For CT Integration In Cath Lab For Guiding Coronary Intervention: A Pilot Study

  Journal of cardiovascular computed tomography · 2025-07-01

• Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning

  Science Advances · 2025-06-06 · 3 citations

• ACR Appropriateness Criteria® Brain Tumors

  Journal of the American College of Radiology · 2025-05-01 · 8 citations